Inspire Medical Systems
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Inspire Medical Systems generated cash of $24,653,000, which is more than the previous year. Cash used in financing activities reached the amount of $13,950,000 last year. Net change in cash is therefore -$256,055,000.
Cash Flow
| 2015 | -22.25M | 23.56M | 2.54M |
|---|---|---|---|
| 2016 | -17.94M | -306K | 12.81M |
| 2017 | -15.79M | -7.6M | 25.66M |
| 2018 | -18.69M | -83.38M | 190.38M |
| 2019 | -32.84M | -43.55M | 1.96M |
| 2020 | -53.04M | 86.62M | 134.06M |
| 2021 | -20.11M | 29.13M | 14.94M |
| 2022 | 11.56M | -19.59M | 235.07M |
| 2023 | 24.65M | -294.82M | 13.95M |
INSP Cash Flow Statement (2015 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 441.59M | 214.46M | 190.51M | 22.86M | 97.28M | 8.95M | 6.68M | 12.12M | 8.27M |
Operating activities | |||||||||
Net income | -21.15M | -44.88M | -42.04M | -57.20M | -33.24M | -21.82M | -17.51M | -18.52M | -21.33M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 2.84M | 1.85M | 1.21M | 840K | 495K | 393K | 285K | 103K | 120K |
Stock-based compensation expense | 82.47M | 51.97M | 26.17M | 12.81M | 6.19M | 0 | 243K | 248K | 305K |
| Deferred income tax benefit | 82.47M | 51.97M | 26.17M | 12.81M | 6.19M | 0 | 243K | 248K | 305K |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | -30.21M | -27.01M | -9.24M | -11.84M | -6.48M | -2.83M | -1.76M | -760K | -261K |
Inventories | -21.99M | 5.34M | -8.75M | -2.64M | -3.16M | 1.00M | -315K | 612K | -1.51M |
Accounts payable | 9.29M | 14.35M | 4.77M | 2.04M | 1.03M | 439K | 1.82M | -480K | 418K |
Cash generated by operating activities | 24.65M | 11.56M | -20.11M | -53.04M | -32.84M | -18.69M | -15.79M | -17.94M | -22.25M |
Investing activities | |||||||||
Purchases Of Investments | -281.43M | -10.5M | -9.99M | -52.72M | -178.07M | -115.48M | -8.96M | 0 | 0 |
Investments In Property Plant And Equipment | -23.62M | -9.09M | -4.66M | -2.45M | -2.73M | -250K | -412K | -306K | -346K |
Acquisitions Net | 0 | 0 | -33.80M | -89.08M | 40.82M | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -294.82M | -19.59M | 29.13M | 86.62M | -43.55M | -83.38M | -7.6M | -306K | 23.56M |
Financing activities | |||||||||
Common Stock Issued | 31.10M | 243.80M | 14.94M | 134.06M | 2.49M | 181.82M | 25.20M | 0 | 42K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -17.15M | 0 | 3.47M | 0 | 1.35M | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -24.5M | 0 | 0 | 0 | 0 | 458K | 0 | 2.5M |
Cash used in financing activities | 13.95M | 235.07M | 14.94M | 134.06M | 1.96M | 190.38M | 25.66M | 12.81M | 2.54M |
Net Change In Cash | -256.05M | 227.12M | 23.94M | 167.65M | -74.42M | 88.33M | 2.27M | -5.44M | 3.85M |
Cash at end of period | 185.53M | 441.59M | 214.46M | 190.51M | 22.86M | 97.28M | 8.95M | 6.68M | 12.12M |
| Data source | Data source | Data source | Data source | Data source | Data source |